will medicare pay for semaglutide for weight loss Medicare, Medicaid cover GLP-1 weight-loss drugs next year Ozempic Medicare Coverage and Co-Pay

Introduction A new class of medications has hit the market and sparked waves in both diabetes and weight loss

Issues with the thyroid, viral infections, bone disease, or fibromyalgia may also be to blame

Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) in December 2025 increased slightly relative to September 2025 (+5.0%) and now account for more than 7% of all prescriptions

adults now use a GLP-1 for weight loss, while 15% say theyve used one at some point, according to Gallup

Its primary benefit in the semaglutide context is combating the fatigue and low energy that many users experience during significant caloric restriction